| 000 | 01570 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516224212.0 | ||
| 264 | 0 | _c20151005 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1751-2980 | ||
| 024 | 7 |
_a10.1111/1751-2980.12177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNalbantoglu, I L Ke | |
| 245 | 0 | 0 |
_aHistological features and severity of oxaliplatin-induced liver injury and clinical associations. _h[electronic resource] |
| 260 |
_bJournal of digestive diseases _cOct 2014 |
||
| 300 |
_a553-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHepatectomy |
| 650 | 0 | 4 |
_aHepatocytes _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadverse effects |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aTan, Benjamin R | |
| 700 | 1 | _aLinehan, David C | |
| 700 | 1 | _aGao, Feng | |
| 700 | 1 | _aBrunt, Elizabeth M | |
| 773 | 0 |
_tJournal of digestive diseases _gvol. 15 _gno. 10 _gp. 553-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1751-2980.12177 _zAvailable from publisher's website |
| 999 |
_c24041159 _d24041159 |
||